ABOUT US
About Us
At HM CIOCC, we offer you comprehensive cancer care, from prevention and early diagnosis to the most advanced treatments.
The leading private oncology center
The Centro Integral Oncológico Clara Campal HM CIOCC (Clara Campal Comprehensive Cancer Center HM CIOCC) is a leader in private oncology in Spain and an international benchmark in cancer treatment. Every year, thousands of patients place their trust in us, drawn by our commitment to a rapid diagnosis and the design of a personalized strategy with the least invasive techniques possible.
Our excellence is based on three pillars: top-tier medical care, constant research, and advanced technology. We are pioneers in Europe with our Unit for Prevention and Hyper-early Oncological Diagnosis, which, along with the Molecular Medicine Unit, allows us to offer you the most innovative techniques in cancer detection and treatment. At HM CIOCC, research translates directly into better treatment options for our patients.
Do you need oncological care?
Call us at 917 567 997 and get an appointment with our oncology medical team in less than 48 hours. Your health is our priority.
HM CIOCC in numbers
4.000
Patients treated
Using the highest standards of quality. Leaders in cancer diagnosis and treatment.
240
Clinical trials
The HM CIOCC Clinical Trials Unit is a leading reference in Spain, conducting over 240 trials each year.
550
Consultations per year
With over 550 consultations annually, our center is a benchmark institution in cancer diagnosis and treatment.
How is the unit organized?
Dr. Antonio Cubillo
Director of HM CIOCC
Dr. Juan Sepulveda
Head of Head and Neck Oncology
Dr. Felipe Casado
Head of Onco-Hematology Department
Dr. Mamen Rubio
Head of Oncologic Radiotherapy Department
Dr. Emiliano Calvo
Director of Clinical Trials HM CIOCC
Dr. Emilio Vicente
Head of General Surgery Department
Dr. Lina García
Head of Nuclear Medicine Department
Our centers
-
The Centro Integral Oncológico Clara Campal HM CIOCC (Clara Campal Comprehensive Cancer Center HM CIOCC), with its main headquarters next to the HM Sanchinarro University Hospital and an extensive network of centers in Madrid, Barcelona, Santiago de Compostela, and Málaga, is a benchmark in oncological care. In 2024, more than 4,000 new patients placed their trust in our team, which conducted over 55,000 consultations and administered more than 18,000 chemotherapy treatments.
Robotic approach
-
Precision and personalization are key in the approach to cancer at HM CIOCC in HM Sanchinarro. That’s why we have the most advanced robotic technology in Spain, including the da Vinci SP, da Vinci Xi, and HUGO RAS systems. This technology, along with the excellence of our Oncologic Radiotherapy service, a leader in the National Health System according to Merco’s MRS in 2024, allows us to offer you high-precision oncological treatments adapted to your needs.
Continuous research and innovation
-
At HM CIOCC, hope lies in research. We promote studies that seek new solutions for cancer, and we offer our patients access to innovative treatments thanks to our cutting-edge clinical research units. Our Phase I Clinical Trials Unit START, a leader in Europe, is a symbol of our commitment to the future of oncology.